IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q4 2024 Holdings

Filed 2025-02-14 | 65 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Viatris Inc(VTRS)COM92556V106$15.8M1,272,1021.4%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$17.5M29,8001.6%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$18.2M719,8361.6%
Bio-Techne Corp(TECH)COM09073M104$21.6M299,3101.9%
Protagonist Therapeutics Inc(PTGX)COM74366E102$26.2M678,7872.3%
Zimvie Inc(ZIMV)COM98888T107$28.9M2,070,7802.6%
Healthequity Inc(HQY)COM42226A107$37.1M386,6973.3%
Revvity Inc(RVTY)COM714046109$43.8M392,5183.9%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$49.4M2,242,1254.4%
HCA Healthcare Inc(HCA)COM40412C101$52.8M175,8084.7%
Inspire MED SYS Inc(INSP)COM457730109$54.6M294,3024.8%
Vera Therapeutics Inc(VERA)CL A92337R101$67.7M1,600,0156.0%
GSK PLC(GSK)SPONSORED ADR37733W204$123.8M3,661,76811.0%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$124.3M243,10011.0%
Natera Inc(NTRA)COM632307104$138.8M876,76612.3%
PreviousPage 2 of 2